# Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate Biopsy

> **NCT03936296** · NA · COMPLETED · sponsor: **TC Erciyes University** · enrollment: 600 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** mpMR guided MR-US fusion transrectal prostate biopsy
- **PROCEDURE:** 12 core standard transrectal prostate biopsy

## Key facts

- **NCT ID:** NCT03936296
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-06
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-08-28
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936296, "Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate Biopsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03936296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*